New Research Facility at Hopkins

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 9 No 2
Volume 9
Issue 2

The Bunting - Blaustein Building stands across the street from the new Weinberg Building that houses Hopkins’ comprehensive clinical cancer services [see ONI Dec. 1999, page 11].

BALTIMORE—Johns Hopkins Medical Institutions has dedicated its new $59 million cancer research facility, named The Bunting Family - The Family of Jacob and Hilda Blaustein Building after the Baltimore philanthropists who donated $20 million toward its construction. The facility contains the laboratories of more than 400 cancer researchers and staff.

The Bunting - Blaustein Building stands across the street from the new Weinberg Building that houses Hopkins’ comprehensive clinical cancer services [see ONI Dec. 1999, page 11].

“By gathering leading cancer investigators under one roof, the new facility will help us build more quickly upon our past successes and advance treatments more effectively,” said Martin D. Abeloff, MD, director of the Johns Hopkins Comprehensive Cancer Center.

Architects for the 10-story, 122,000 net square foot building were HDR Architecture Inc. in association with Zimmer Gunsul Frasca Partnership.

Recent Videos
Data from the SPOTLIGHT and GLOW trials reveal that zolbetuximab increased survival in patients with CLDN18.2-positive gastric or GEJ adenocarcinoma.
The incorporation of zolbetuximab in addition to chemotherapy has shown benefit in patients with Claudin 18.2–positive gastric cancers in clinical trials.
Michael J. Hall, MD, MS, FASCO, discusses the need to reduce barriers to care for those with Li-Fraumeni syndrome, including those who live in rural areas.
Patrick Oh, MD, highlights next steps for further research in treating patients with systemic therapy in addition to radiotherapy for early-stage NSCLC.
The ability of metformin to disrupt mitochondrial metabolism may help mitigate the risk of cancer in patients with Li-Fraumeni syndrome.
Related Content